(Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today highlighted capabilities of its ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced its ...

HANGZHOU Ustar Biotechnology Company, a giant molecular diagnostic firm with a footprint around the world, is keen to expand ...

Co-Diagnostics, Inc. announced its upcoming participation at WHX Labs Johannesburg, taking place October 6-8, 2026, at the Gallagher Convention Centre in Johannesburg, South Africa. Attendees are ...

Tuberculosis still kills more people than any other infectious disease, yet the single greatest obstacle to controlling it is ...

A five-year Chinese hospital study of 5,123 women with tuberculosis shows that genital tuberculosis overwhelmingly strikes ...

Measurement of calcium-dependent host immune proteins reveals distinct features that may inform point-of-care testing.

Global efforts, driven by public health campaigns and modern antiretroviral therapies, have steadily reduced new HIV infections around the world.

Motilal Oswal sees Molbio Diagnostics evolving beyond TB testing as Truenat kits, HPV assays, imaging and digital pathology ...

Molbio Diagnostics is entering a faster-growth phase, with Jefferies seeing Truenat expansion and the scaling of Prognosys and OptraScan as key earnings drivers.

The Executive Order establishes a federal initiative focused on suppressing tick and mosquito populations and addressing vector-borne disease through improved detection, screening, prevention and ...

Unlike clinicians in Europe, clinicians in North America did not have a guideline on managing bronchiectasis in adults, and ...